United States · Series D startup

Who invested in ILiAD Biotechnologies

2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 9 months ago

Funding summaryUpdated 26 Oct 2026

$116Mraised across 2 rounds since 2015, from 2 sources

$640KVenture$115MSeries D
Latest round
Series D, $115MFeb 2026
Step-upi
179.7×
Investors
4
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20172019202120232025
$640KVenture$115MSeries D
First round
Venture, $640K
Nov 2015
Biggest round
$115M
Series D · Feb 2026
Between rounds
10.3 years
from the last two

The rounds

  1. Feb 2026
    Series D$115M4 new

    Source recordedSEC filing: $116M sold, first sale Feb 2026

  2. Nov 2015
    Venture$640K

    No investor was named in the report.

    From a historical funding recordSEC filing: $640K sold, first sale Oct 2015

Founders and team

From ILiAD Biotechnologies's own website: 3 on the team.

  • Avi NaiderBoard Member
  • James T. WassilBoard Member
  • Suha JhaveriBoard Member

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

RA Capital ManagementPrivate equity1round
BNP ParibasVC firm1round
Janus Henderson InvestorsPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about ILiAD Biotechnologies

Who invested in ILiAD Biotechnologies?

ILiAD Biotechnologies's investors include RA Capital Management, BNP Paribas, Janus Henderson Investors and National Institute of Allergy and Infectious Diseases.

How much has ILiAD Biotechnologies raised?

ILiAD Biotechnologies has raised $116M across 2 rounds since 2015.

When did ILiAD Biotechnologies last raise?

ILiAD Biotechnologies's most recent round was a Series D of $115M in Feb 2026.

What was ILiAD Biotechnologies's biggest round?

Its most recent round, $115M in Feb 2026, is also its largest on record.

Who backed ILiAD Biotechnologies first?

ILiAD Biotechnologies's first round on record, in Feb 2026, was backed by RA Capital Management, BNP Paribas and Janus Henderson Investors and 1 others.

What stage is ILiAD Biotechnologies at?

ILiAD Biotechnologies's latest named round is a Series D, in Feb 2026.

Where is ILiAD Biotechnologies based?

ILiAD Biotechnologies is based in the United States.

Companies like ILiAD Biotechnologies

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.